Browse grants

Department of Transportation · $100K–$10M

Funds infrastructure projects that reduce traffic fatalities and serious injuries on public roads, administered by California's Division of Local Assistance under the federal Highway Safety Improvement Program (23 U.S.C. §148). Open only to public agencies and tribal governments — not nonprofits, businesses, or individuals — for projects justified by crash data, crash rate, or crash-reduction potential. Awards range from $100,000 to $10,000,000 and are due 2026-11-03.

U.S. National Science Foundation · $160K–$170K

This NSF program provides postdoctoral research fellowships in the social, behavioral, and economic sciences, supporting an individual fellow's research and training early in their career. Proposals are submitted by the individual postdoc, not an institution, and the award goes directly to the fellow; applicants must be U.S. citizens, nationals, or permanent residents who recently earned (or will soon earn) a doctorate and do not hold a tenure-track position. The fellowship is held at a U.S. institution of higher education or a nonprofit non-academic research organization, with award amounts of roughly $160,000 to $170,000. This is narrowly aimed at eligible individual early-career researchers, not organizations.

National Institutes of Health · Amount varies

This NIH U01 grant funds research using expanded-access data for investigational drugs to help intermediate-size populations of ALS patients who are not eligible for ongoing clinical trials; a clinical trial is required. Eligibility is narrow: applicants must be clinical trial sites participating in a phase 2/3 or phase 3 trial sponsored by a small business that is the FDA-designated sponsor of the relevant drug. Foreign organizations and foreign components are not eligible. No award amounts are listed. This is a highly specialized opportunity tied to an existing small-business-sponsored ALS drug trial, not a general grant.

National Institutes of Health · Up to $1.1M

NIH (NCCIH) R33 funding for early-phase clinical trials of natural products (botanicals, dietary supplements, probiotics) to confirm target engagement and inform whether further clinical research is warranted. Intended for research institutions; foreign organizations are not eligible. The listed maximum is about $1,050,000. It will not support efficacy or effectiveness trials and requires strong preliminary data, making it narrow research-only funding.

National Institutes of Health · Up to $750K

NIH (NIDA) K12 institutional career-development funding to support mentored research training for clinician-scientists in substance use and substance use disorder research. Intended for institutions that will run a scholar training program; foreign organizations are not eligible and foreign components are not allowed. The listed maximum is about $750,000. This is an institutional training award, not a grant for individuals or general nonprofits.

National Institutes of Health · Amount varies

NIH (NCCIH) R01 funding for mid-phase clinical trials of natural products such as botanicals, dietary supplements, and probiotics that already have strong preliminary data. Intended for research institutions able to conduct hypothesis-driven, milestone-based clinical trials; foreign organizations are not eligible. No dollar amount is stated. It will not support efficacy/effectiveness trials or cancer-treatment trials, and requires substantial prior preliminary data, so it is narrow in scope.

National Institutes of Health · Up to $350K

NIH (NCCIH) phased R61/R33 funding for early-phase clinical trials of natural products (botanicals, probiotics, marketed dietary supplements) with a strong scientific rationale. Suited to research institutions running milestone-driven pharmacokinetic and target-engagement studies; foreign organizations are not eligible. The listed maximum is about $350,000. It is narrow research-only work requiring strong preliminary justification, not a fit for individuals or general nonprofits.

Environmental Protection · Amount varies

This program exclusively funds Pennsylvania county government agencies — county health departments, conservation districts, emergency management offices, and similar county units — for mosquito-borne disease surveillance and control (West Nile virus, Zika, etc.). It requires a contract with PA's Department of Environmental Protection plus quarterly invoicing and reporting; nonprofits, businesses, and non-Pennsylvania applicants are not eligible. Award amounts are not specified, and the deadline is November 15, 2026.

Defense Health Agency Contracting Activity - DHACA · Amount varies

Department of War (Defense Health Agency) Joint Warfighter Military Medical Research and Development Award funding the continuation of prior DoD/DoW-funded research toward high-priority military medical needs. A key restriction is that applicants must already have received DoD/DoW core or Congressional Special Interest funding, so this is limited to existing DoD-funded performers. No award amount is specified. Eligibility is narrow due to the prior-funding requirement.

National Institutes of Health · Up to $50K

This NIH grant (up to $50,000) funds small research projects studying the ethical, legal, and social implications (ELSI) of human genetics and genomics, including single-investigator studies, preliminary data collection, and secondary data analysis. It's aimed at eligible U.S. and territorial research institutions. The deadline is November 16, 2026.

U.S. National Science Foundation · $100K–$4M

NSF Major Research Instrumentation program funding the acquisition or development of multi-user research instruments. Eligibility is limited to US institutions of higher education and US not-for-profit, non-degree-granting research organizations with 501(c)(3) status; for-profit firms can participate only as subaward partners and cannot apply directly. Awards range from about $100,000 up to $4,000,000. This is narrowly scoped to research institutions and large in size.

U.S. National Science Foundation · $600K–$2M

NSF Translation to Practice (TTP) program funding the translation of research results toward real-world products, services, and partnerships. Eligibility is limited to US nonprofits/non-academic research organizations and US institutions of higher education, and the PI must hold a tenured/tenure-track or full-time research/teaching appointment; the TTP-E track additionally requires an active eligible NSF research award. Awards range from about $600,000 up to $2,000,000. Eligibility is narrow given the active-award and appointment requirements.

National Institutes of Health · Amount varies

This NIH R01 funds investigator-initiated, fully remote clinical trials testing complementary and integrative health interventions (with no in-person contact and possible mHealth tools) in NCCIH's priority research areas. Applicants must justify the remote approach and provide feasibility and safety preliminary data. It's aimed at eligible U.S. research institutions, and the deadline is November 17, 2026.

National Institutes of Health · Amount varies

NIH (NIAAA) phased R61/R33 funding for research on preventing prenatal alcohol exposure and developing interventions for fetal alcohol spectrum disorders. Intended for research institutions and investigators, including minority-serving and tribal colleges; advancement to the R33 phase depends on meeting milestones. No award amount is stated. This is institution-based research funding with priority for clinical-trial applications, not suited to individuals or general nonprofits.

National Institutes of Health · Up to $200K

NIH (NCI) R21 funding for secondary analysis and integration of existing datasets to study cancer risk and related outcomes; clinical trials are not allowed under this notice. Intended for research institutions and investigators, including minority-serving and tribal colleges. The listed maximum is about $200,000. This is institution-based research funding using existing data, not suited to individuals or general nonprofits.

National Institutes of Health · Up to $350K

NIH (NCCIH) R01 funding for multi-site feasibility clinical trials of mind-and-body interventions to prepare for a later full-scale efficacy trial. Intended for research institutions able to coordinate across multiple sites; foreign organizations are not eligible (foreign components allowed). The listed maximum is about $350,000. Sufficient preliminary data from prior single-site work is required, making this narrowly scoped research funding.

National Institutes of Health · Amount varies

This NIH R34 grant funds feasibility trials of mind-and-body complementary health interventions for NCCIH-designated high-priority conditions, generating data needed to plan a subsequent full-scale efficacy or effectiveness trial. Applicants are encouraged to consult NCCIH staff before applying, and it's aimed at eligible U.S. research institutions. The deadline is November 17, 2026.

National Institutes of Health · Amount varies

This NIH R01 grant funds research applications studying the ethical, legal, and social implications of human genetics and genomics, using empirical, conceptual, legal, or normative methods. Applications must include a Plan for Enhancing Diverse Perspectives (PEDP); those without one won't be reviewed. It's aimed at eligible U.S. and territorial research institutions, and the deadline is November 18, 2026.

U.S. National Science Foundation · Amount varies

NSF FINDERS FOUNDRY program funding partnerships of K-12 educators, technologists, and researchers to develop technology-based solutions to learning and workforce challenges, with a focus on early AI exposure. Eligible applicants are limited to US nonprofits/non-academic research organizations, state and local governments, US institutions of higher education, and federally recognized tribal nations; unaffiliated individuals cannot apply and no PI degree is required. Only teams awarded planning grants may later submit development proposals. No award amount is specified.

National Institutes of Health · Amount varies

This NIH R21 grant funds exploratory and developmental research into the ethical, legal, and social implications of human genetics and genomics, particularly studies examining new or emerging genomic technologies. It's open to eligible U.S. and territorial research institutions using empirical, conceptual, legal, or normative methods. The deadline is November 18, 2026.